Industry & Business

Dublin startup scores €85 million funding for new approach to cancer therapy

 Breaking News
  • HBAN Scoops Major European Business Angel Network Award HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment, and a joint initiative of Enterprise Ireland and InterTradeIreland, was crowned Globally Networked Organisation 2018 at the recent EBAN (European Business Angel Network) Awards Ceremony held in Sofia, Bulgaria. HBAN was awarded the prominent European accolade in recognition of the significant [...]...
  • Irish Whiskey Industry Welcomes EU-Japan Trade Agreement The Irish Whiskey Association has welcomed the signing of the EU-Japan Economic Partnership Agreement, the largest trade deal negotiated yet by the European Union. While sales of Irish whiskey remain relatively low, Japan is currently the largest market in Asia for Irish whiskey and last year Irish whiskey sales in Japan recorded a 15.7% growth to [...]...
  • BD Opens New State-of-the-art R&D Facility in Limerick BD, a leading global medical technology company, is to create 85 new jobs for the Limerick region. The announcement was made as Minister for Trade, Employment, Business, EU Digital Single Market and Data Protection Pat Breen TD, officially opened BD’s Research Centre Ireland (RCI) in Limerick’s National Technology Park. The €21 million investment in BD’s [...]...
  • National Project Awards 2018 Open For Entries Entries for the Ireland Chapter of Project Management Institute’s (PMI) National Project Awards, sponsored by PwC, are open. Over 120 applicants entered the awards last year, which celebrate the country’s leading project managers and teams and their forward-thinking projects. This year the Awards recognise the importance of community-led non-profit projects with the introduction of a new [...]...
  • McAleer & Rushe Transforming Edinburgh’s Old Town The new UK Government hub planned for New Waverley in the heart of Edinburgh’s Old Town, which is being constructed by Northern Ireland-based design and build company McAleer & Rushe, has reached a significant milestone with the official ‘Topping Out’ of the office scheme. The project which is transforming a UNESCO Heritage site, in one [...]...

Dublin startup scores €85 million funding for new approach to cancer therapy

Dublin startup scores €85 million funding for new approach to cancer therapy
October 04
10:07 2016

Carrick Therapeutics, a Dublin-based startup specialising in a unique approach to cancer therapies, has launched having secured $95 (€85) million in funding.

Heavyweight investors have lined up to support the Irish company, with US firm ARCH Venture Partners, leading UK firm Woodford Investment Management and GV (Google Ventures) among those who have provided the capital. Lightstone Ventures, which is supported by Enterprise Ireland and the Irish Strategic Investment Fund, has also support Carrick.

The company will aim to build an innovative portfolio of first-in-class treatments that are advanced through understanding the mechanisms that cause cancer and resistance and tailored to an individual patient’s tumour.

Personalised cancer medicine, which is targeted at that specific patient’s cancer, is seen as a crucial next step in the fight against the disease. Cancer is so difficult to treat because of its unpredictability, but new scientific advances are developing more and more of an understanding about it affects each person.

Carrick Therapeutics has set out a clear vision to target the molecular pathways that drive the most aggressive and resistant forms of cancer in order to have a major impact on the lives of patients. With such large funding, the company will look to develop a portfolio of first-in-class treatments, rather than a single compound or biological mechanism.

Their CEO, Dr Elaine Sullivan, has previously worked as Vice President for Research and Development for pharma giants Eli Lilly and AstraZeneca.

She comments: “Our aim is to build Europe’s leading oncology company. There is a significant unmet need in cancer treatment, and targeting aggressive and resistant disease is an area where we can make a real difference to patients’ lives.”

Sullivan has indicated that Ireland was an ideal choice for their base of operations due to the opportunities for collaboration with clinicians and scientists, and because its skilled workforce makes it a great place for recruitment.

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4